drugset / Trial / NCT03032484
TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma
RandomizedParallel-groupOpen-labelTreatment
Summary
Randomized phase 2 study TVB-2640 in combination with Bevacizumab versus Bevacizumab alone.
Timeline
- Start
- 2017-05-18
- Primary completion
- 2020-04-04
- Completion
- 2021-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Denifanstat | Small molecule | 100 mg/m2 | — |
| Background | Bevacizumab | Monoclonal antibody | — | — |